CYTOSORBENTS CORPORATION Common Stock, Value, Issued
CYTOSORBENTS CORPORATION (CTSO) had Common Stock, Value, Issued of $63.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-06
- 2026-06-30: Common Stock, Value, Issued $63.00K.
- 2026-03-31: Common Stock, Value, Issued $63.00K.
- 2025-12-31: Common Stock, Value, Issued $63.00K.
- 2025-09-30: Common Stock, Value, Issued $63.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $63.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $63.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $63.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $63.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $63.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $62.53K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $55.00K 10-K · filed 2026-03-30 | $54.83K 10-K · filed 2025-03-31 |
| 2024-09-30 | $54.50K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $54.31K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $54.29K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $54.24K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $44.44K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $44.19K 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $43.85K 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $43.63K 10-K · filed 2024-03-15 | |
| 2022-09-30 | $43.63K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $43.58K 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $43.51K 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $43.48K 10-K · filed 2023-03-09 | |
| 2021-09-30 | $43.48K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $43.34K 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $43.27K 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $43.22K 10-K · filed 2022-03-10 | |
| 2020-09-30 | $43.18K 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $36.81K 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $36.13K 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $32.62K 10-K · filed 2021-03-09 | |
| 2019-09-30 | $32.42K 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $32.30K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $32.24K 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $31.77K 10-K · filed 2020-03-05 | |
| 2018-09-30 | $31.63K 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $31.42K 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $29.97K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $28.97K 10-K · filed 2019-03-07 | |
| 2017-09-30 | $28.48K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $28.13K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $25.55K 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $25.48K 10-K · filed 2018-03-08 | |
| 2016-09-30 | $25.47K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $25.44K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $25.41K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $25.40K 10-K · filed 2017-03-03 | |
| 2015-09-30 | $25.18K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $24.89K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $24.68K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $23.30K 10-K · filed 2016-03-09 | |
| 2014-09-30 | $322.77K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $310.40K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $299.03K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $10.05K 10-K · filed 2015-03-31 | $251.32K 10-K · filed 2014-03-31 |
| 2013-09-30 | $245.14K 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $234.40K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $228.95K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $214.97K 10-K · filed 2014-03-31 | |
| 2012-09-30 | $209.90K 10-Q · filed 2012-11-21 | |
| 2012-06-30 | $199.05K 10-Q · filed 2012-08-13 | |
| 2012-03-31 | $189.84K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $177.63K 10-K · filed 2013-04-03 | |
| 2011-09-30 | $172.28K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $165.87K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $122.84K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |